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Point of care (POC) diagnostic technologies has 
gained much attention in the biomedical community 
as a methodology for early screening to diagnose and 
monitor the effectiveness of therapeutics (companion 
diagnostics) that is cost-effective and easy to use. The 
ability to utilize POC diagnostics to screen and quantify 
biomarkers associated with disease prognosis and 
predictive therapeutic response would assist dentists/
physicians in their treatment selection1.
The evolution of POC diagnostic technologies 
demonstrates that technology development is at a point 
in which it can address clinical needs. Simple chemical/
colorimetric methods were quickly developed into dipstick 
type formats that have been used by physicians at the 
first stage of patient assessment; an example of this 
is the urine analysis in a clinical setting. Urine samples 
are easily obtained non-invasively without requiring 
technical or a highly-trained person4. There also have 
been recent attempts to use finger-prick (minimally 
invasive) volumes of blood samples to diagnose and 
monitor infectious disease using on-chip microdevices2. 
While many variations of these devices have been utilized 
for blood-borne biomarkers of disease, the use of saliva 
as a diagnostic fluid has not gained much traction due 
to methodological and technological obstacles related 
to the fluid itself as the viscosity and presence of high 
abundant proteins (mucins) and microbial contaminations 
(if one is not targeting this population). Though, given its 
availability (and the fact most patients visit their dentist 
just as often as their primary care physician), the non-
invasive nature of collection, relative low cost of testing, 
and proximity to oral tissues, saliva would be an ideal fluid 
for oral diagnostics. Advantages to this approach is that 
many diagnostic analytes in serum have been found in 
saliva and these observations give saliva the potential for 
use in therapeutic drug monitoring, as is being developed 
for epilepsy, and in the diagnosis of systemic disorders 
such as impaired cardiovascular function, renal disease, 
cancer, and viral and bacterial infections.
The benefits of early detection are critical to improving 
the outcome of treatment, survival rate, quality of life, and 
cost of care of many diseases. Limited screening tests exist 
for common oral diseases such as caries, periodontitis 
and oral cancer, resulting in many late- and end-stage 
diagnoses and poor prognoses. 
The combination of using the novel use of microparticles 
isolated from saliva with microfluidic technologies hold 
promise for diagnosing disease, monitoring disease 
progression and evaluating therapeutic responses. 
Traditional diagnostic methods test for the presence of 
specific DNA or RNA molecules associated with a variety 
of disease states that require labor-intensive sample 
preparation that typically involves cell lysis, nucleic acid/
protein isolation, enrichment, purification and detection.   
Advancements in POC diagnostic technology development 
permits micro- and nano-scale reaction volumes where 
all the steps can be incorporated on a “lab-on-a-chip”, 
which is a miniaturized device, such as a cassette, that 
can then be inserted into a portable detection analyzer. 
Such devices also allow for the simultaneous evaluation 
of multiple analytes (multi-plexing) from a single fluid 
sample, which may be required for the detection and 
analysis of complex diseases such as periodontitis and 
oral cancer. For example, in monitoring the progression 
of periodontitis, the analysis of a panel of biomarkers 
associated with the inflammatory process (IL-1B, MMP-8, 
and ICTP) is shown to have significantly higher diagnostic 
value than the measurement of a single biomarker. 
The use of saliva as a diagnostic fluid presents several 
challenges related to low abundant analytes that can 
be addressed by a two or three component microfluidic 
device. The amount of analytes tend to be much lower in 
concentration in saliva when compared to that of serum 
that can be mitigated by employing analyte enrichment 
techniques or utilizing a more sensitive detection method 
such as using quantum dot technology (nanoparticles 
display unique optical and electrical properties). 
In summary, there are numerous advantages to using 
microfluidic salivary diagnostics from the non-invasive 
method of saliva collection that causes minimal discomfort 
and anxiety, which can improve patient compliance for 
testing to the benefits of lab-on-a-chip device for clinical 
diagnostics to include scalability, low-cost, disposable 
devices, the use of small sample volumes, limited 
exposure to and use of chemical reagents, automated 
process and rapid processing times. Additionally, on the 
global health related issues, portable, fully-automated 
analyzing systems can provide considerable benefit to the 
healthcare of persons in rural or remote regions which may 
lack sophisticated laboratory facilities or highly-trained 
personnel. The parallel progress in salivary biomarker 
discovery and microfluidic processing methodologies has 
made it possible for the development of lab-on-a-chip 
devices for potential diagnosis and monitoring of many 
oral and systemic diseases3. Continued research in these 
fields will lead to the widespread adoption of salivary 
diagnostics in the near future.  
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